RXi Technology Shows Potential as miRNA Mimic In Vitro

RXi and Miragen used the technology to create an miRNA mimic capable of down-regulating a reporter gene whose expression is controlled by the microRNA in cell culture model systems.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.